Archer T, Arweström E, Jonsson G, Minor B G, Post C
Acta Pharmacol Toxicol (Copenh). 1985 Oct;57(4):255-61. doi: 10.1111/j.1600-0773.1985.tb00040.x.
The effect of pretreatment with the noradrenaline neurotoxin, N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4), upon the analgesia induced by various doses of 5-hydroxytryptamine (5-HT) was examined in rats and mice. DSP4 treatment (2 X 50 mg/kg, intraperitoneally) of rats caused a complete blockade of 5-HT induced analgesia in the tail-flick, hot-plate and shock titration tests. DSP4 treatment (1 X 50 mg/kg, intraperitoneally) of mice caused a partial blockade of 5-HT induced analgesia in the hot-plate test, but no significant blockade in the tail-flick test. These results are discussed with regard to serotonergic-noradrenergic interactions and the species discrepancy in nociceptive testing.
研究了用去甲肾上腺素神经毒素N - 2 - 氯乙基 - N - 乙基 - 2 - 溴苄胺(DSP4)预处理对不同剂量5 - 羟色胺(5 - HT)诱导的大鼠和小鼠镇痛作用的影响。给大鼠腹腔注射DSP4(2×50mg/kg)后,在甩尾、热板和电击滴定试验中,5 - HT诱导的镇痛作用完全被阻断。给小鼠腹腔注射DSP4(1×50mg/kg)后,在热板试验中,5 - HT诱导的镇痛作用部分被阻断,但在甩尾试验中无明显阻断作用。结合5 - 羟色胺能 - 去甲肾上腺素能相互作用以及伤害性测试中的种属差异对这些结果进行了讨论。